Generic Name and Formulations:
Ivermectin 3mg, 6mg+; tabs; +scored.
Merck & Co., Inc.
Indications for STROMECTOL:
Intestinal strongyloidiasis due to Strongyloides stercoralis. Onchocerciasis due to immature Onchocerca volvulus.
Adults and Children:
Take with water. Give as a single dose. <15kg: not recommended. Strongyloidiasis: 200mcg/kg. Onchocerciasis: 150mcg/kg; may retreat after 3 months.
Hyperreactive onchodermatitis. Immunocompromised. Pregnancy (Cat.C), nursing mothers: not recommended.
Strongyloidiasis: dizziness, pruritus, GI disturbances. Onchocerciasis: Mazzotti reactions (eg, arthralgia/synovitis, swollen lymph nodes), ophthalmologic effects, pruritus, rash, fever, tachycardia, edema, hypotension.
Tabs 3mg—20; 6mg—10
Neurology Advisor Articles
- Erenumab Superior to Placebo for Reducing Migraine Disability, Improving HRQoL
- Managing Status Epilepticus in Palliative Care: Accounting for Patient and Family Experience
- Congress Passes Bill to Fight Opioid Crisis
- Physical Activity Decreases Vascular Comorbidities in Multiple Sclerosis
- Review of Factors Impacting Sport-Related Concussion Headaches
- Anodal tDCS Offers Possible Benefit for Improving Item Recall in Post-Stroke Aphasia
- Hospitalization Tied to Brain Abnormalities in Older Adults
- Spending Often Persists in High-Cost Medicare-Medicaid Eligible
- Skills-Based Intervention Did Not Cut Systolic BP After Stroke, TIA
- High Frequency of Headaches Following Dialysis Associated With BUN and Blood Pressure